PEB is in a linear regression channel
Printable View
PEB is in a linear regression channel
http://www.computerworld.co.nz/artic..._companies_us/
“The trip is about giving New Zealand companies access to key business people in San Francisco and Silicon Valley, and generating business opportunities and potential investment options,” Adams says.
Bizarrely, this is starting to sound a little like the DIL thread.
What I am seeing is a large investor selling with perhaps a minority of nervous nellies along for the ride. The 6% recovery in the last couple of days is suggestive that the seller may be done or is taking a hiatus for now.
IMO the forward growth story for PEB is just way too strong for any transient weakness to take hold. The closer we get to half year reporting the more the market may well anticipate this growth.
but the recovery is on very thin volume mac, such as yesterday, so a large possibility the large seller has not yet finished.
It could well move into a consolidation period at 49-51 cents, depends on out large seller though eh?
Agree with the story.
Its a great announcement - would love to know by how much cxBladderDetect outperformed cytology in the study. A wide margin sounds great though.
Also liked: "We look forward to having this product more widely used in New Zealand’s healthcare programmes, thus benefiting DHBs, clinicians and patients alike."
It all adds to the saleability of the product in the US - fantastic.
I think you are right AndyLP, there may not be any significant new news in this announcement, but the timing of its release and it's focus suggests perhaps that the DHB's may now be at a tipping point of getting their order books out now that surely all those trials have been done and dusted to some level of satisfaction.